Arkolith/Insider Trading/ELTX/Form 4

Chudnovsky Yekaterina

Director, 10% OwnerElicio Therapeutics, Inc. (ELTX) · full profile →Form 4 · filed Mar 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2025Conversion(C)3.5M$5.81$20.3M5.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 5, 2025Conversion(C)3.4M$5.81$20.0M0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-035494) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML